Green Cross Holdings Corporation

KSE 005250.KS

Green Cross Holdings Corporation Inventory for the year ending December 31, 2023: USD 445.23 M

Green Cross Holdings Corporation Inventory is USD 445.23 M for the year ending December 31, 2023, a 11.58% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Green Cross Holdings Corporation Inventory for the year ending December 31, 2022 was USD 399.02 M, a -5.97% change year over year.
Green Cross Holdings Corporation Inventory for the year ending December 31, 2021 was USD 424.35 M, a -5.50% change year over year.
Green Cross Holdings Corporation Inventory for the year ending December 31, 2020 was USD 449.03 M, a 14.80% change year over year.
Green Cross Holdings Corporation Inventory for the year ending December 31, 2019 was USD 391.15 M, a 1.40% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

KSE: 005250.KS

Green Cross Holdings Corporation

CEO	Mr. Il-Sup Huh Ph.D.
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	107, Ihyeon-ro 30beon-gil
Employees	154
Sector	Health Care
Industries Biotechnology Pharmaceuticals Vaccines

Description

Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for hemophilia. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies. Green Cross Holdings was founded in 1967 and is headquartered in Yongin, South Korea.

Key trends

Past 5 years